Assessment and characterisation of common renal masses with CT and MRI

Pallwein-Prettner, Leo; Flöry, Daniel; Rotter, Claus Raphael; Pogner, Kurt; Syré, G; Fellner, Claudia; Frauscher, Ferdinand; Krause, F; Fellner, Franz A.

doi:10.1007/s13244-011-0116-1

Cited by 33 publications

(31 citation statements)

References 55 publications

Supporting

Mentioning

Contrasting

Unclassified

Order By: Relevance

“…The main differential diagnosis involves the distinction between the minimal fat renal AMLs, oncocytomas, and RCCs [21,22]. Minimal fat AMLs includes two entities, the epithelioid (EAML) and triphasic minimal fat AML (TAML).…”

Section: Differential Diagnosis Between Benign and Malignant Tumoursmentioning

confidence: 99%

Contrast enhanced ultrasound of renal masses. A reappraisal of EFSUMB recommendations and possible emerging applications.

et al. 2015

View full text Add to dashboard Cite

The main imagistic method for characterization of renal lesions is contrast enhanced computed tomography (CECT). Disadvantages of CECT are a contrast-induced nephropathy in patients with renal impairment, allergic reactions and high costs. Contrast-enhanced ultrasound (CEUS) evaluation of hepatic and non-hepatic lesions is a relatively new, but increasingly utilised, diagnostic method. In 2011 the European Federation of Societies of Ultrasound in Medicine and Biology (EFSUMB) updated the Guidelines and Recommendations on the Clinical Practice of CEUS and included in the recommendation the renal pathology. However, there are several possible new indications that have not been discussed (pyelocaliceal masses and renal vein thrombosis) and several issues that remain controversial such as the differentiation of benign and malignant tumours or the differentiation of lymphoma and metastasis.This study aims to review literature data, as well as reveal the latest findings in the field of renal CEUS.

show abstract

Section: Differential Diagnosis Between Benign and Malignant Tumoursmentioning

confidence: 99%

Contrast enhanced ultrasound of renal masses. A reappraisal of EFSUMB recommendations and possible emerging applications.

et al. 2015

View full text Add to dashboard Cite

show abstract

“…Of those <3 cm, 100% were hypointense [22]. In such cases, percutaneously targeted biopsy will aid in the diagnosis [6,22].…”

Section: Magnetic Resonance Imaging In the Diagnosis Of Srmmentioning

confidence: 99%

“…Percutaneous biopsy can be performed if histological confirmation is required [6]. When the decision has been made to treat, SRM can be treated with surgical excision by either a radical nephrectomy (RN) or partial nephrectomy (PN).…”

Section: Introductionmentioning

confidence: 99%

Magnetic Resonance Imaging and the Use in Small Renal Masses

Vedanayagam

Bhattacharya

Sriprasad

2016

Indian J Surg Oncol

View full text Add to dashboard Cite

The incidence of small renal masses (SRM) has been increasing, and this is mainly attributed to the incidental finding of such masses on imaging performed in asymptomatic patients. Consequently, this calls for careful evaluation and management of these masses to determine their nature and need for treatment. This article reviews current literature regarding the evaluation and management of SRM. It focuses on the specific use of MRI in the diagnosis and management of SRM. A Medline review of the literature was performed from 1996 to the present time. Computed tomography (CT) imaging has been the investigation of choice for evaluating SRM. However, some remain difficult to determine their malignant or benign nature and remain indeterminate. In such cases, further imaging with magnetic resonance imaging (MRI) can be performed to evaluate the mass in more detail. It can also be used where CT is contraindicated and where active surveillance is the treatment of choice and radiation exposure is a concern. MRI is a useful tool in evaluating an indeterminate small renal mass. Accurate diagnosis and management of SRM require close collaboration between a urologist and radiologist to identify potentially malignant tumours to subsequently reduce mortality from renal cell cancer.

show abstract

“…Pemilihan imej ini ditentukan daripada sokongan faktor densiti yang memuaskan, hingar latar belakang dan penghasilan kontras imej yang sangat bagus (Pallwein-Prettner et al 2011). Namun begitu, tiada skala tetap klasifi kasi bagi penilaian imej yang dilakukan secara subjektif kerana ia bergantung sepenuhnya kepada mata pemerhati semata-mata.…”

Section: Perbincanganunclassified